Author: "Massie, Barry M." / Publisher: elsevier bv - Searchworks@Jio Institute Digital Library Search Results

Your search keyword '"Massie, Barry M."' showing total 169 results

Start Over Author "Massie, Barry M." Publisher elsevier bv

169 results on '"Massie, Barry M."'

1. Long-Term Effect of Endothelin Receptor Antagonism With Bosentan on the Morbidity and Mortality of Patients With Severe Chronic Heart Failure

Author: Packer, Milton, primary, McMurray, John J.V., additional, Krum, Henry, additional, Kiowski, Wolfgang, additional, Massie, Barry M., additional, Caspi, Avi, additional, Pratt, Craig M., additional, Petrie, Mark C., additional, DeMets, David, additional, Kobrin, Isaac, additional, Roux, Sebastien, additional, Swedberg, Karl, additional, Packer, Milton, additional, Pratt, Craig, additional, Massie, Barry, additional, McMurray, John, additional, Connally, Eugene, additional, Petrie, Mark, additional, Anderson, Susan, additional, Barnet, Jody, additional, Cody, Robert, additional, Dargie, Henry, additional, Francis, Gary, additional, Greenberg, Barry, additional, Reichen, Juerg, additional, Karrasch, J., additional, Krum, H., additional, Horowitz, J., additional, Amerena, J., additional, Sindone, A., additional, MacDonald, P., additional, Jeffrey, I., additional, Button, I., additional, DeAngelis, E., additional, Pacher, R., additional, Davies, R., additional, McAlister, F., additional, Tanser, P., additional, Sussex, B., additional, Baumann, G., additional, Fleck, E., additional, Olbrich, H.-G., additional, Werdan, K., additional, Klein, H., additional, Staffeld, F., additional, Zeiher, A.M., additional, Roediger, C., additional, Caspi, A., additional, Marmor, A., additional, Reisin, L., additional, Vered, Z., additional, Klainman, E., additional, Roguin, N., additional, Tzivoni, D., additional, David, D., additional, Lewis, B., additional, Abinader, E., additional, Omary, M., additional, Rosenman, Y., additional, Kaluski, E., additional, Breedveld, R.W., additional, van der Burgh, P.H., additional, Dunselman, P.H.J.M., additional, Schaafsma, H.J., additional, Hertzberger, D.P., additional, Holwerda, N.J., additional, Kragten, J.A., additional, van Wijngaarden, J., additional, Posma, J.L., additional, Said, S.A.M., additional, Slegers, L.C., additional, Tjon Joe Gin, R.M., additional, Wempe, F.N., additional, Wesdorp, J.C.L., additional, Willems, A.R., additional, Withagen, A.J.A.M., additional, Cornel, J.M., additional, van Kempen, L.H.J., additional, Kiowski, W., additional, Bertel, O., additional, Moccetti, T., additional, McMurray, J.J.V., additional, Greenbaum, R.A., additional, Bennett, P., additional, Swan, J., additional, Davies, G., additional, Findlay, I., additional, Gould, B., additional, Ball, S., additional, Hubner, P., additional, Lahiri, A., additional, McLay, J., additional, Northcote, R., additional, Saltissi, S., additional, Squire, I., additional, Stephens, J., additional, Stewart, M., additional, Bridgen, G., additional, Walsh, J., additional, Webb, D.J., additional, Ansari, Z., additional, Baron, S., additional, Bellinger, R., additional, Bennet, W., additional, Benvenuti, D., additional, Dawley, D., additional, Egbujiobi, L.C., additional, Eisenstein, I., additional, Little, T., additional, Hertsberg, A., additional, Greenspan, M., additional, Grossman, R.J., additional, Hanley, P., additional, Jesrani, M., additional, Kashou, H., additional, Levites, R., additional, Malik, R., additional, Marmorstein, B., additional, Schwartz, M., additional, Nisar, A., additional, Perelman, R., additional, Schwarz, M.L., additional, Sedlis, S., additional, Srebro, J., additional, Taveras, M., additional, Weiss, R., additional, Weitzman, P., additional, Wetherley, G.K., additional, El Shahawy, M., additional, Kereiakes, D., additional, Campos, L., additional, Peterson, G., additional, Small, R.S., additional, Davis, W.R., additional, Olivari, M.-T., additional, Meengs, W., additional, Koren, M., additional, Slagona, P., additional, Jennison, S., additional, Hershberger, R., additional, Browne, K.F., additional, Farnham, D.J., additional, Zelenkofske, S., additional, Lawless, C., additional, Nathan, M., additional, Meyer, T., additional, Kukin, M., additional, Parekh, H., additional, Berkowitz, R., additional, Boehmer, J., additional, Brozena, S., additional, Dandona, P., additional, Dec, G.W., additional, DeQuattro, V., additional, Fenster, P., additional, Fowler, M., additional, Ellaham, S., additional, Geller, M., additional, Gheorgiade, M., additional, Ghali, J., additional, Murali, S., additional, Katz, S., additional, Bott-Silverman, C., additional, Singh, B., additional, Thadani, U., additional, Torre, G., additional, Teerlink, J., additional, Chandraratna, T., additional, Kesselbrenner, M., additional, Mukherjee, A., additional, Che-Pin Tsai, C., additional, Abbo, K., additional, Goldberg, M., additional, Smith, T., additional, and Martin, R.T., additional
Published: 2017
Full Text: View/download PDF

2. Effect of Beta-Blockade on Mortality in Patients With Heart Failure: A Meta-Analysis of Randomized Clinical Trials 11All editorial decisions for this article, including selection of referees, were made by a Guest Editor. This policy applies to all articles with authors from the University of California San Francisco

Author: Heidenreich, Paul A, Lee, Tina T, and Massie, Barry M
Subjects: Cardiology and Cardiovascular Medicine
Abstract: Objectives. We sought to evaluate the current evidence for an effect of beta-blockade treatment on mortality in patients with congestive heart failure (CHF).Background. Although numerous small studies have suggested a benefit with beta-blocker therapy in patients with heart failure, a clear survival benefit has not been demonstrated. A recent combined analysis of several studies with the alpha- and beta-adrenergic blocking agent carvedilol demonstrated a significant survival advantage; however, the total number of events was small. Furthermore, it is unclear if previous studies with other beta-blockers are consistent with this finding.Methods. Randomized clinical trials of beta-blockade treatment in patients with CHF from January 1975 through February 1997 were identified using a MEDLINE search and a review of reports from scientific meetings. Studies were included if mortality was reported during 3 or more months of follow-up.Results. We identified 35 reports, 17 of which met the inclusion criteria. These studies included 3,039 patients with follow-up ranging from 3 months to 2 years. Beta-blockade was associated with a trend toward mortality reduction in 13 studies. When all 17 reports were combined, beta-blockade significantly reduced all-cause mortality (random effect odds ratio [OR] 0.69, 95% confidence interval [CI] 0.54 to 0.88). A trend toward greater treatment effect was noted for nonsudden cardiac death (OR 0.58, 95% CI 0.40 to 0.83) compared with sudden cardiac death (OR 0.84, 95% CI 0.59 to 1.2). Similar reductions in mortality were observed for patients with ischemic (OR 0.69, 95% CI 0.49 to 0.98) and nonischemic cardiomyopathy (OR 0.69, 95% CI 0.47 to 0.99). The survival benefit was greater for trials of the drug carvedilol (OR 0.54, 95% CI 0.36 to 0.81) than for noncarvedilol drugs (OR 0.82, 95% CI 0.60 to 1.12); however, the difference did not reach statistical significance (p = 0.10).Conclusions. Pooled evidence suggests that beta-blockade reduces all-cause mortality in patients with CHF. Additional trials are required to determine whether carvedilol differs in its effect from other agents.(J Am Coll Cardiol 1997;30:27–34)
Published: 1997
Full Text: View/download PDF

3. Double-blind, placebo-controlled study of the efficacy of flosequinan in patients with chronic heart failure

Author: Packer, Milton, Narahara, Kenneth A., Elkayam, Uri, Sullivan, Jay M., Pearle, David L., Massie, Barry M., Creager, Mark A., and The Principal Investigators of the Reflect Study
Subjects: medicine.medical_specialty, Ejection fraction, Intention-to-treat analysis, Digoxin, business.industry, medicine.medical_treatment, Placebo-controlled study, medicine.disease, Placebo, Surgery, Heart failure, Anesthesia, medicine, Diuretic, business, Flosequinan, Cardiology and Cardiovascular Medicine, medicine.drug
Abstract: Objectives. The aim of this study was to assess the efficacy of flosequinan in chronic heart failure. Background. Flosequinan is a new vasodilator drug that acts by interfering with the inositol-triphosphate/protein kinase C pathway, an important mechanism of vasoconstriction. The drug dilates both peripheral arteries and veins, is orally active and has a long duration of action that permits once-daily dosing. Previous studies have shown that flosequinan produces sustained hemodynamic benefits in heart failure, but large scale studies evaluating its clinical efficacy have not been reported. Methods. One hundred ninety-three patients with chronic heart failure (New York Heart Association functional class II or III and left ventricular ejection fraction
Published: 1993
Full Text: View/download PDF

4. Facilitation of a Multihospital Community of Practice to Increase Enrollment in the Hospital to Home National Quality Improvement Initiative

Author: Heidenreich, Paul A., primary, Sahay, Anju, additional, Mittman, Brian S., additional, Oliva, Nancy, additional, Gholami, Parisa, additional, Rumsfeld, John S., additional, and Massie, Barry M., additional
Published: 2015
Full Text: View/download PDF

5. Worsening Heart Failure Following Admission for Acute Heart Failure

Author: Davison, Beth A., primary, Metra, Marco, additional, Cotter, Gad, additional, Massie, Barry M., additional, Cleland, John G.F., additional, Dittrich, Howard C., additional, Edwards, Christopher, additional, Filippatos, Gerasimos, additional, Givertz, Michael M., additional, Greenberg, Barry, additional, Ponikowski, Piotr, additional, Voors, Adriaan A., additional, O’Connor, Christopher M., additional, and Teerlink, John R., additional
Published: 2015
Full Text: View/download PDF

6. Comparative Assessment of Short-Term Adverse Events in Acute Heart Failure With Cystatin C and Other Estimates of Renal Function

Author: Tang, W.H. Wilson, primary, Dupont, Matthias, additional, Hernandez, Adrian F., additional, Voors, Adriaan A., additional, Hsu, Amy P., additional, Felker, G. Michael, additional, Butler, Javed, additional, Metra, Marco, additional, Anker, Stefan D., additional, Troughton, Richard W., additional, Gottlieb, Stephen S., additional, McMurray, John J., additional, Armstrong, Paul W., additional, Massie, Barry M., additional, Califf, Robert M., additional, O’Connor, Christopher M., additional, and Starling, Randall C., additional
Published: 2015
Full Text: View/download PDF

7. High-Sensitivity C-Reactive Protein in Acute Heart Failure: Insights From the ASCEND-HF Trial

Author: Kalogeropoulos, Andreas P., primary, Tang, W. H. Wilson, additional, Hsu, Amy, additional, Felker, G. Michael, additional, Hernandez, Adrian F., additional, Troughton, Richard W., additional, Voors, Adriaan A., additional, Anker, Stefan D., additional, Metra, Marco, additional, McMurray, John J.V., additional, Massie, Barry M., additional, Ezekowitz, Justin A., additional, Califf, Robert M., additional, O’Connor, Christopher M., additional, Starling, Randall C., additional, and Butler, Javed, additional
Published: 2014
Full Text: View/download PDF

8. Medical Resource Use, Costs, and Quality of Life in Patients With Acute Decompensated Heart Failure: Findings From ASCEND-HF

Author: Reed, Shelby D., primary, Kaul, Padma, additional, Li, Yanhong, additional, Eapen, Zubin J., additional, Davidson-Ray, Linda, additional, Schulman, Kevin A., additional, Massie, Barry M., additional, Armstrong, Paul W., additional, Starling, Randall C., additional, O’Connor, Christopher M., additional, Hernandez, Adrian F., additional, and Califf, Robert M., additional
Published: 2013
Full Text: View/download PDF

9. Clinical Pharmacy Services in Heart Failure: An Opinion Paper From the Heart Failure Society of America and American College of Clinical Pharmacy Cardiology Practice and Research Network

Author: Milfred-LaForest, Sherry K., primary, Chow, Sheryl L., additional, DiDomenico, Robert J., additional, Dracup, Kathleen, additional, Ensor, Christopher R., additional, Gattis-Stough, Wendy, additional, Heywood, J. Thomas, additional, Lindenfeld, JoAnn, additional, Page, Robert L., additional, Patterson, J. Herbert, additional, Vardeny, Orly, additional, and Massie, Barry M., additional
Published: 2013
Full Text: View/download PDF

10. The Predictive Value of Short-Term Changes in Hemoglobin Concentration in Patients Presenting With Acute Decompensated Heart Failure

Author: van der Meer, Peter, primary, Postmus, Douwe, additional, Ponikowski, Piotr, additional, Cleland, John G., additional, O'Connor, Christopher M., additional, Cotter, Gad, additional, Metra, Marco, additional, Davison, Beth A., additional, Givertz, Michael M., additional, Mansoor, George A., additional, Teerlink, John R., additional, Massie, Barry M., additional, Hillege, Hans L., additional, and Voors, Adriaan A., additional
Published: 2013
Full Text: View/download PDF

11. Effect of Levosimendan on the Short-Term Clinical Course of Patients With Acutely Decompensated Heart Failure

Author: Packer, Milton, primary, Colucci, Wilson, additional, Fisher, Lloyd, additional, Massie, Barry M., additional, Teerlink, John R., additional, Young, James, additional, Padley, Robert J., additional, Thakkar, Roopal, additional, Delgado-Herrera, Leticia, additional, Salon, Jeffrey, additional, Garratt, Chris, additional, Huang, Bidan, additional, and Sarapohja, Toni, additional
Published: 2013
Full Text: View/download PDF

12. Long-term electrical survival analysis of Riata and Riata ST silicone leads: National Veterans Affairs experience

Author: Sung, Raphael K., primary, Massie, Barry M., additional, Varosy, Paul D., additional, Moore, Hans, additional, Rumsfeld, John, additional, Lee, Byron K., additional, and Keung, Edmund, additional
Published: 2012
Full Text: View/download PDF

13. CTST-21: A Phase 2, Randomized, Double-Blind, Multi-Center Study Comparing 15G Cross-Linked Polyelectrolyte (CLP) versus Placebo in Heart Failure Patients with Chronic Kidney Disease

Author: Massie, Barry M., primary, Costanzo, Maria Rosa, additional, Heywood, J. Thomas, additional, Iwashita, Julie, additional, Hernderson, Lee, additional, Mamatsashvili, Merab, additional, Sisakian, Hamayak, additional, Hayrapetyan, Hamlet, additional, Sager, Philip, additional, van Veldguisen, Dirk J., additional, and Albrecht, Detlef, additional
Published: 2012
Full Text: View/download PDF

14. The Heart Failure Society of America in 2020: A Vision for the Future

Author: Greenberg, Barry H., primary, Anand, Inder S., additional, Burnett, John C., additional, Chin, John, additional, Dracup, Kathleen A., additional, Feldman, Arthur M., additional, Force, Thomas, additional, Francis, Gary S., additional, Houser, Steven R., additional, Hunt, Sharon A., additional, Konstam, Marvin A., additional, Lindenfeld, JoAnn, additional, Mann, Douglas L., additional, Mehra, Mandeep R., additional, Paul, Sara C., additional, Piano, Mariann R., additional, Ross, Heather J., additional, Sabbah, Hani N., additional, Starling, Randall C., additional, Udelson, James E., additional, Yancy, Clyde W., additional, Zile, Michael R., additional, and Massie, Barry M., additional
Published: 2012
Full Text: View/download PDF

15. Novel targets for the treatment of heart failure: Perspectives from a heart failure clinician and trialist

Author: Massie, Barry M., primary
Published: 2011
Full Text: View/download PDF

16. Characteristics of Implantable Cardioverter-defibrillator Recipients for the Primary and Secondary Prevention of Sudden Cardiac Death in the Outcomes Among Veterans With Implantable Defibrillators (OVID) Registry

Author: Katz, David F., primary, Aleong, Ryan G., additional, Pointer, Lauren, additional, Pelligrini, Cara N., additional, Sauer, William H., additional, Heath, Russell R., additional, Schuller, Joseph, additional, Nguyen, Duy T., additional, Heidenreich, Paul A., additional, Massie, Barry M., additional, and Varosy, Paul D., additional
Published: 2011
Full Text: View/download PDF

17. Globalization of Clinical Trials

Author: Massie, Barry M., primary
Published: 2011
Full Text: View/download PDF

18. Reply

Author: Ghali, Jalal K., primary, Massie, Barry M., additional, Mann, Douglas L., additional, and Rich, Michael W., additional
Published: 2011
Full Text: View/download PDF

19. Effects of the Adenosine A1 Receptor Antagonist Rolofylline on Renal Function in Patients With Acute Heart Failure and Renal Dysfunction

Author: Voors, Adriaan A., primary, Dittrich, Howard C., additional, Massie, Barry M., additional, DeLucca, Paul, additional, Mansoor, George A., additional, Metra, Marco, additional, Cotter, Gad, additional, Weatherley, Beth D., additional, Ponikowski, Piotr, additional, Teerlink, John R., additional, Cleland, John G.F., additional, O'Connor, Christopher M., additional, and Givertz, Michael M., additional
Published: 2011
Full Text: View/download PDF

20. ACCF/AHA/HFSA 2011 Survey Results: Current Staffing Profile of Heart Failure Programs, Including Programs That Perform Heart Transplant and Mechanical Circulatory Support Device Implantation

Author: Jessup, Mariell, primary, Albert, Nancy M., additional, Lanfear, David E., additional, Lindenfeld, JoAnn, additional, Massie, Barry M., additional, Walsh, Mary Norine, additional, and Zucker, Mark J., additional
Published: 2011
Full Text: View/download PDF

21. Guidelines are Merely Guidelines

Author: Ghali, Jalal K., primary, Massie, Barry M., additional, Mann, Douglas L., additional, and Rich, Michael W., additional
Published: 2011
Full Text: View/download PDF

22. Heart Failure Guidelines, Performance Measures, and the Practice of Medicine

Author: Ghali, Jalal K., primary, Massie, Barry M., additional, Mann, Douglas L., additional, and Rich, Michael W., additional
Published: 2010
Full Text: View/download PDF

23. History of Heart Failure and Mortality among Veterans With Implantable Cardioverter-Defibrillators

Author: Varosy, Paul D., primary, Pellegrini, Cara N., additional, Yang, Yanfei, additional, Keung, Edmund, additional, Heidenreich, Paul, additional, Rumsfeld, John S., additional, and Massie, Barry M., additional
Published: 2010
Full Text: View/download PDF

24. Clinical Subtype of Atrial Fibrillation at the Time of Implantation and Subsequent Mortality among Veterans With Implantable Defibrillators

Author: Aleong, Ryan, primary, Sauer, William H., additional, Pellegrini, Cara N., additional, Yang, Yanfei, additional, Keung, Edmund, additional, Heidenreich, Paul, additional, Rumsfeld, John S., additional, Massie, Barry M., additional, and Varosy, Paul D., additional
Published: 2010
Full Text: View/download PDF

25. National Heart, Lung, and Blood Institute Working Group on Emergency Department Management of Acute Heart Failure

Author: Peacock, W. Frank, primary, Braunwald, Eugene, additional, Abraham, William, additional, Albert, Nancy, additional, Burnett, John, additional, Christenson, Rob, additional, Collins, Sean, additional, Diercks, Deborah, additional, Fonarow, Greg, additional, Hollander, Judd, additional, Kellerman, Art, additional, Gheorghiade, Mihai, additional, Kirk, Doug, additional, Levy, Phil, additional, Maisel, Alan, additional, Massie, Barry M., additional, O'Connor, Christopher, additional, Pang, Peter, additional, Shah, Monica, additional, Sopko, George, additional, Stevenson, Lynne, additional, Storrow, Alan, additional, and Teerlink, John, additional
Published: 2010
Full Text: View/download PDF

26. BASELINE SYSTOLIC BLOOD PRESSURE AND OUTCOMES IN PATIENTS WITH HEART FAILURE AND PRESERVED EJECTION FRACTION - RESULTS FROM THE I-PRESERVE TRIAL

Author: Anand, Inderjit S., primary, Hetzel, Scott J., additional, Miller, Alan B., additional, Carson, Peter E., additional, Gaasch, William H., additional, Haass, Markus, additional, Little, William C., additional, Lopez-Sendon, Jose, additional, Massie, Barry M., additional, McMurray, John J., additional, Ptaszynska, Agata, additional, Teerlink, John R., additional, White, Michel, additional, and Zile, Michael R., additional
Published: 2010
Full Text: View/download PDF

27. ACUTE CORONARY SYNDROMES IN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION: A HARBINGER OF DEATH?

Author: Teerlink, John R., primary, Zile, Michael R., additional, White, Michel, additional, Miller, Alan B., additional, Lopez-Sendon, Jose, additional, Little, William C., additional, Haass, Markus, additional, Anand, Inderjit S., additional, Ptaszynska, Agata, additional, Hetzel, Scott J., additional, Komajda, Michel, additional, McMurray, John JV, additional, Massie, Barry M., additional, Carson, Peter E., additional, and Investigators, I-Preserve, additional
Published: 2010
Full Text: View/download PDF

28. Baseline Plasma NT-proBNP and Clinical Characteristics: Results From the Irbesartan in Heart Failure With Preserved Ejection Fraction Trial

Author: Mckelvie, Robert S., primary, Komajda, Michel, additional, Mcmurray, John, additional, Zile, Michael, additional, Ptaszynska, Agata, additional, Donovan, Mark, additional, Carson, Peter, additional, and Massie, Barry M., additional
Published: 2010
Full Text: View/download PDF

29. The Journal of Cardiac Failure: Passing the Baton

Author: Massie, Barry M., primary
Published: 2010
Full Text: View/download PDF

30. Design and Rationale of the PROTECT Study: A Placebo-controlled Randomized Study of the Selective A1 Adenosine Receptor Antagonist Rolofylline for Patients Hospitalized With Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function

Author: Weatherley, Beth Davison, primary, Cotter, Gad, additional, Dittrich, Howard C., additional, DeLucca, Paul, additional, Mansoor, George A., additional, Bloomfield, Daniel M., additional, Ponikowski, Piotr, additional, O'Connor, Christopher M., additional, Metra, Marco, additional, and Massie, Barry M., additional
Published: 2010
Full Text: View/download PDF

31. Resource Use and Costs of Treatment With Anticoagulation and Antiplatelet Agents: Results of the WATCH Trial Economic Evaluation

Author: Patterson, Mark E., primary, Grant, William C., additional, Glickman, Seth W., additional, Massie, Barry M., additional, Ammon, Susan E., additional, Armstrong, Paul W., additional, Cleland, John G.F., additional, Collins, Joseph F., additional, Teo, Koon K., additional, Schulman, Kevin A., additional, and Reed, Shelby D., additional
Published: 2009
Full Text: View/download PDF

32. Atrial Fibrillation at Baseline and During Follow-Up in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial)

Author: Haywood, L. Julian, primary, Ford, Charles E., additional, Crow, Richard S., additional, Davis, Barry R., additional, Massie, Barry M., additional, Einhorn, Paula T., additional, and Williard, Angela, additional
Published: 2009
Full Text: View/download PDF

33. Troponin Release in Patients Admitted with Acute Decompensated Heart Failure and Renal Dysfunction: Results from the Pilot Phase of the PROTECT Trial

Author: Metra, Marco, primary, Dittrich, Howard C., additional, Cotter, Gad, additional, Massie, Barry M., additional, Ponikowski, Piotr, additional, Jia, Gang, additional, Fujita, Kenji P., additional, and O'Connor, Christopher M., additional
Published: 2009
Full Text: View/download PDF

34. Phase III clinical trial end points in acute heart failure syndromes: A virtual roundtable with the acute heart failure syndromes international working group

Author: Gheorghiade, Mihai, primary, Adams, Kirkwood F., additional, Cleland, John G.F., additional, Cotter, Gad, additional, Felker, G. Michael, additional, Filippatos, Gerasimos S., additional, Fonarow, Gregg C., additional, Greenberg, Barry H., additional, Hernandez, Adrian F., additional, Khan, Sadiya, additional, Komajda, Michel, additional, Konstam, Marvin A., additional, Liu, Peter P., additional, Maggioni, Aldo P., additional, Massie, Barry M., additional, McMurray, John J., additional, Mehra, Mandeep, additional, Metra, Marco, additional, O'Connell, John, additional, O'Connor, Christopher M., additional, Pang, Peter S., additional, Piña, Ileana L., additional, Sabbah, Hani N., additional, Teerlink, John R., additional, Udelson, James E., additional, Yancy, Clyde W., additional, Zannad, Faiez, additional, and Stockbridge, Norman, additional
Published: 2009
Full Text: View/download PDF

35. The PROTECT Pilot Study: A Randomized, Placebo-Controlled, Dose-Finding Study of the Adenosine A1 Receptor Antagonist Rolofylline in Patients With Acute Heart Failure and Renal Impairment

Author: Cotter, Gad, primary, Dittrich, Howard C., additional, Davison Weatherley, Beth, additional, Bloomfield, Daniel M., additional, O'connor, Christopher M., additional, Metra, Marco, additional, and Massie, Barry M., additional
Published: 2008
Full Text: View/download PDF

36. The Effects of KW-3902, an Adenosine A1-Receptor Antagonist,on Diuresis and Renal Function in Patients With Acute Decompensated Heart Failure and Renal Impairment or Diuretic Resistance

Author: Givertz, Michael M., primary, Massie, Barry M., additional, Fields, Tara K., additional, Pearson, Leeanne L., additional, and Dittrich, Howard C., additional
Published: 2007
Full Text: View/download PDF

37. Trends in Heart Failure Hospitalization Rate and Outcome in the United States

Author: Heidenreich, Paul A., primary, Sahay, Anju, additional, Costa, Martin M., additional, and Massie, Barry M., additional
Published: 2007
Full Text: View/download PDF

38. Effects of Multiple Oral Doses of an A1Adenosine Antagonist, BG9928, in Patients With Heart Failure

Author: Greenberg, Barry, primary, Thomas, Ignatius, additional, Banish, Dorothy, additional, Goldman, Steven, additional, Havranek, Edward, additional, Massie, Barry M., additional, Zhu, Ying, additional, Ticho, Barry, additional, and Abraham, William T., additional
Published: 2007
Full Text: View/download PDF

39. β-Blocker dosing in community-based treatment of heart failure

Author: Fowler, Michael B., primary, Lottes, Sandra R., additional, Nelson, Jeanenne J., additional, Lukas, Mary Ann, additional, Gilbert, Edward M., additional, Greenberg, Barry, additional, Massie, Barry M., additional, Abraham, William T., additional, and Franciosa, Joseph A., additional
Published: 2007
Full Text: View/download PDF

40. Comparison of Outcomes and Usefulness of Carvedilol Across a Spectrum of Left Ventricular Ejection Fractions in Patients With Heart Failure in Clinical Practice

Author: Massie, Barry M., primary, Nelson, Jeanenne J., additional, Lukas, Mary Ann, additional, Greenberg, Barry, additional, Fowler, Michael B., additional, Gilbert, Edward M., additional, Abraham, William T., additional, Lottes, Sandra R., additional, and Franciosa, Joseph A., additional
Published: 2007
Full Text: View/download PDF

41. The Second Follow-up Serial Infusions of Nesiritide (FUSION II) trial for advanced heart failure: Study rationale and design

Author: Yancy, Clyde W., primary, Krum, Henry, additional, Massie, Barry M., additional, Silver, Marc A., additional, Stevenson, Lynne Warner, additional, Cheng, Mei, additional, Kim, Sun Sook, additional, and Evans, Rosemary, additional
Published: 2007
Full Text: View/download PDF

42. The Utility of Gestures in Patients with Chest Discomfort

Author: Marcus, Gregory M., primary, Cohen, Joshua, additional, Varosy, Paul D., additional, Vessey, Joshua, additional, Rose, Emily, additional, Massie, Barry M., additional, Chatterjee, Kanu, additional, and Waters, David, additional
Published: 2007
Full Text: View/download PDF

43. The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) heart failure Validation Study: Diagnosis and prognosis

Author: Einhorn, Paula T., primary, Davis, Barry R., additional, Massie, Barry M., additional, Cushman, William C., additional, Piller, Linda B., additional, Simpson, Lara M., additional, Levy, Daniel, additional, Nwachuku, Chuke E., additional, and Black, Henry R., additional
Published: 2007
Full Text: View/download PDF

44. Predictors of Clinical Outcomes in Patients Given Carvedilol for Heart Failure

Author: Greenberg, Barry, primary, Lottes, Sandra R., additional, Nelson, Jeanenne J., additional, Lukas, Mary Ann, additional, Fowler, Michael B., additional, Massie, Barry M., additional, Abraham, William T., additional, Gilbert, Edward M., additional, and Franciosa, Joseph A., additional
Published: 2006
Full Text: View/download PDF

45. Effects of the Adenosine A1 Receptor Antagonist, KW-3902, Alone and in Combination with Furosemide, on Diuresis and Renal Function in Hospitalized Acutely Decompensated Heart Failure Patients with Renal Impairment or Refractory to Maximum Dose of Conventional Diuretics: Two Randomized, Double-Blind, Placebo-Controlled Studies.

Author: Givertz, Michael M., primary, Fields, Tara K., additional, Pearson, Leanne L., additional, Dittrich, Howard C., additional, Cotter, Gad, additional, and Massie, Barry M., additional
Published: 2006
Full Text: View/download PDF

46. Utility of Impedance Cardiography for the Identification of Short-Term Risk of Clinical Decompensation in Stable Patients With Chronic Heart Failure

Author: Packer, Milton, primary, Abraham, William T., additional, Mehra, Mandeep R., additional, Yancy, Clyde W., additional, Lawless, Christine E., additional, Mitchell, Judith E., additional, Smart, Frank W., additional, Bijou, Rachel, additional, O’Connor, Christopher M., additional, Massie, Barry M., additional, Pina, Ileana L., additional, Greenberg, Barry H., additional, Young, James B., additional, Fishbein, Daniel P., additional, Hauptman, Paul J., additional, Bourge, Robert C., additional, Strobeck, John E., additional, Murali, Srinvivas, additional, Schocken, Douglas, additional, Teerlink, John R., additional, Levy, Wayne C., additional, Trupp, Robin J., additional, and Silver, Marc A., additional
Published: 2006
Full Text: View/download PDF

47. The Year in Heart Failure 2005

Author: Massie, Barry M., primary and Force, Thomas, additional
Published: 2006
Full Text: View/download PDF

48. The Irbesartan in Heart Failure With Preserved Systolic Function (I-PRESERVE) Trial: Rationale and Design

Author: Carson, Peter, primary, Massie, Barry M., additional, McKelvie, Robert, additional, McMurray, John, additional, Komajda, Michel, additional, Zile, Michael, additional, Ptaszynska, Agata, additional, and Frangin, Gerald, additional
Published: 2005
Full Text: View/download PDF

49. Silent Cerebral Infarction in Heart Failure: Vascular or Thromboembolic?

Author: Freudenberger, Ronald S., primary and Massie, Barry M., additional
Published: 2005
Full Text: View/download PDF

50. Aspirin Use in Chronic Heart Failure

Author: Massie, Barry M., primary
Published: 2005
Full Text: View/download PDF

Catalog

Books, media, physical & digital resources

See catalog results

Searchworks

Select search scope, currently: Articles Catalog books, media & more in Jio Institute collections Articles journal articles & other e-resources

Search

Search Constraints

Refine your results

Search Limiters

Topic

Publication Year Range

Language

Journal

Database

169 results on '"Massie, Barry M."'

Search Results

Catalog

Select search scope, currently: Articles

Catalog

books, media & more in Jio Institute collections

Articles

journal articles & other e-resources